BONSAI: Biomarkers of Nonsteroidal Anti-Inflammatories
Status:
Unknown status
Trial end date:
2009-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to test the effect of ibuprofen on the levels of a number of
different proteins (called biomarkers) in cerebrospinal fluid (CSF), blood, and urine to see
whether ibuprofen can influence certain biomarkers associated with the progression of
Alzheimer's Disease.